![]() |
|
|

*
Department of Life and Health Sciences, Hyogo University of Teacher Education, Yashiro, Hyogo 673-1494, Japan; and
Department of Food Science and Nutrition, Nara Womens University, Nara 630-8506 Japan
1To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: apoptosis DHA tumor necrosis factor U937 cells vitamin E
| INTRODUCTION |
|---|
|
|
|---|
B (Beg and Baltimore 1996
B activation
(Munoz et al. 1997
Dietary (n-3) fatty acids, abundant in fish oil, have been reported to
possess the potential to reduce chronic inflammatory diseases through
attenuating activities of inflammatory lipid mediators or
pro-inflammatory cytokines including TNF. Intake of docosahexaenoic
acid [DHA, 22:6(n-3)] and eicosapentaenoic acid [EPA, 20:5(n-3)]
can reduce the generation of eicosanoids derived from arachidonic acid
[AA, 20:4(n-6)] (Simopoulos 1991
). Several human
studies have shown that supplementation of (n-3) fatty acids in the
diet results in reduced ex vivo production of TNF (Calder 1997
). Furthermore, there is evidence raising the possibility
that (n-3) fatty acids could affect the cellular response to cytokines,
especially cytolysis induced by TNF. It has been suggested that AA
release may be involved in the cytotoxic action of TNF
(Palombella and Vilcek 1989
, Suffys et al. 1987
). Recent findings indicate that AA-specific type IV
cytosolic phospholipase A2 (cPLA2) may play an
essential role in TNF-induced apoptosis (Enari et al. 1996
, Hayakawa et al. 1993
,
Voelkel-Johnson et al. 1996
, Wissing et al. 1997
, Wu et al. 1998
). These observations imply
that supplementation of (n-3) fatty acid may affect cytolysis caused by
TNF, because DHA and/or EPA inhibit AA metabolism at various enzymatic
steps (Simopoulos 1991
). Especially, DHA possesses
distinctive inhibitory activity against cPLA2
(Shikano et al. 1993
, 1994
). However, in
contrast to the regulatory activity of (n-3) fatty acids on the
synthesis of TNF, effect of (n-3) fatty acids on cellular response to
cytotoxic action of TNF has not been fully investigated.
In this study, we examined the effect of supplementation of DHA, EPA
and AA to human monocytic U937 cell cultures on the apoptosis induced
by TNF. As observed in our previous study using sphingosine as an
apoptosis-inducing agent (Kishida et al. 1998
), only
DHA showed the potent ability to attenuate TNF-induced apoptosis.
Furthermore, the synergistic effect of vitamin E, the principal
antioxidant vitamin that has been reported to reduce cell death
elicited by various apoptotic stimuli (Barroso et al. 1997
, Haendeler et al.1996
, Ikeda et al. 1999
, Straface et al. 1995
), was examined to
assess to what extent nutrients can attenuate TNF-induced
apoptosis. Our data indicated that, even though the main signal
transducing system for TNF-induced apoptosis is considered to be
precisely programmed through protein/protein interaction (Green 1998
), DHA and vitamin E can separately or synergistically
reduce the proportion of apoptotic cells. These results imply that
nutrients could regulate pathophysiological conditions in which
TNF-induced apoptosis plays an important role.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Fatty acid-free bovine serum albumin (BSA), AA, EPA, DHA and
bisbenzimide (Hoechst 33342) were purchased from Sigma (St. Louis, MO).
-Tocopherol (vitamin E), cycloheximide (CHI) and Proteinase K were
from Wako Pure Chemicals (Osaka, Japan). RNase A and SYBR Green were
from Takara Biochemical (Ohtsu, Japan) and Molecular Probes Inc.
(Rockland, ME), respectively. RPMI 1640 medium, fetal bovine serum
(FBS), L-glutamine and kanamycin were obtained from Gibco
BRL (Grand Island, NY). TNF was from Boehringer Mannheim Biochemica
(Germany). Arachidonoyl trifluoromethylketone
(AACOCF3) and methyl
arachidonoylfluorophosphonate (MAFP) were from Biomol Research
Laboratory (Plymouth Meeting, PA) and Caymman Chemical (Ann Arbor, MI),
respectively.
Cell culture.
Human monocytic U937 cells were obtained from the Riken Cell Bank (Tsukuba, Japan). Cells were maintained in RPMI 1640 medium containing 10% heat-inactivated FBS, L-glutamine and kanamycin (10% FBS-RPMI1640) at 37°C in a humidified atmosphere of 5% CO2 and subcultured every 5 or 6 d. In the preincubation with various supplements or stimulation with TNF and CHI, 10% FBS-RPMI1640 was used as culture medium, but cells were stimulated in serum-free medium by TNF without CHI.
Induction of apoptosis and effect of supplementation of fatty acid and/or vitamin E.
Fatty acid (AA, EPA or DHA) was conjugated with fatty acid-free BSA in a 1:5 M ratio. A stock solution of vitamin E was prepared in ethanol. Cells (1.0 x 106 cells/mL) were incubated in 10% FBS-RPMI1640 supplemented with the fatty acids and/or vitamin E for 24 h. Cell viability is affected by high concentration of ethanol or vitamin E. However, we confirmed that the incubation with 1 mmol/L vitamin E did not affect the viability, and kept cell growth normally under our preincubation condition. In the stimulation with TNF alone, cells were washed after the preincubation, suspended at a density of 2 x 106 cells/mL in serum-free medium and allowed to re-equilibrate for 1 h without the supplements. Cells were then treated with TNF (100 µg/L) for 3 h. In the stimulation with TNF + CHI, cells were washed after the preincubation, suspended in 10% FBS-RPMI1640 (2 x 106 cells/mL) and prewarmed for 1 h without the supplements. Apoptosis was induced with a combination of TNF (0.52.0 µg/L) and CHI (1 mg/L). In this concentration of CHI, maximal induction of apoptosis was observed with fixed concentration of TNF, and higher amounts of CHI in the combination of TNF reduced apoptotic cell percentage. Without TNF, this concentration of CHI reduced cell growth to 10% of that without CHI, indicating that protein synthesis was reduced, but not completely inhibited by this concentration of CHI.
Assay of apoptosis.
Morphological changes in the nuclear chromatin of cells undergoing
apoptosis were detected using an Olympus IMT2-RFL fluorescence
microscope after fixation and staining with bisbenzimide (Hoechst
33342) as described previously (Kishida et al. 1997
).
Data were expressed as means ± SD for at least three
independent analyses. The inhibition rate of apoptosis was calculated
as follows: 100 x {(A - B) - (C
- D)}/(A - B). A is
percentage apoptosis by the inducer (TNF); B is percentage
of apoptosis by the vehicle of the inducer; C is percentage
apoptosis in the presence of both the inducer and the inhibitor;
D is percentage apoptosis in the presence of the inhibitor.
DNA fragmentation was assessed by agarose gel electrophoresis as
described previously (Kishida et al. 1997
). Briefly,
cells (1 x 106 cells) were lysed in 0.5% Triton X
containing 10 mmol/L Tris-HCl (pH7.4) and 5 mmol/L EDTA for 20 min
on ice. The lysate was centrifuged at 27000 x g for 15
min at 4°C. The supernatant was treated with Proteinase K (100 µg).
DNA in the supernatant was extracted with phenol-chloroform and
precipitated with 0.3 mol/L sodium acetate and 80% ethanol at
-20°C. The DNA was treated with RNase A, prior to loading onto a
2.0% agarose gel (6 x 104 cells/lane). DNA bands were
visualized under UV light after staining with SYBR Green.
Effect of cPLA2 inhibitors on the apoptosis induced by TNF.
AACOCF3 or MAFP was dissolved in DMSO and added to the cell suspension at the final concentration of 10 µmol/L. The final concentration of DMSO was 0.1%. After the addition of AACOCF3 or MAFP, cells were preincubated for 1 h in the presence of 10% FBS, and TNF (2 µg/L) and CHI (1 mg/L) were then added without changing the medium.
Lipid analysis.
Cell lipids were extracted by the method of Bligh and Dyer (1959)
and
separated by TLC as described previously (Shikano et al. 1994
). The bands corresponding to phospholipids were scraped
from the plates. The fatty acid esters of phospholipids were converted
to methyl esters and quantified by gas chromatography with a capillary
column as described previously (Kishida et al. 1998
).
Statistical methods.
All statistical analyses were carried out using SPSS (version 9.0; SPSS Inc., Chicago, IL) software. After ascertaining the values to be homoscedastic by Levenes test, one-way or two-way ANOVA was applied. Difference of each group mean from control value was analyzed using Dunnetts t posthoc procedure. When the values were not homoscedastic, Kruskal-Wallis test was applied for the analysis instead of ANOVA, and difference between two groups was analyzed by Dunnetts T3 procedure.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
|
|
|
|
|
|
Vitamin E is an effective scavenger of oxygen radicals and alkyl
radicals. However, when added to the cell culture, it takes several
hours for a detectable amount to enter into the cells (Ikeda et al. 1999
). Therefore cells were preincubated with vitamin E for
24 h which was thought to be sufficient to elevate intracellular
vitamin E. During this preincubation, vitamin E can reduce the
peroxidation of PUFA in cell culture. This may explain the inhibitory
activity of vitamin E and the synergistic effect with DHA. However,
N-acetylcysteine or 2-mercaptoethanol, a synthetic
antioxidant, added to the cell culture simultaneously with TNF and CHI
significantly inhibited TNF-induced apoptosis (Yano, M., Kishida,
E., and Masuzawa, Y., unpublished observation). This implies that the
effectiveness of another antioxidant, vitamin E, is not only due to the
suppression of lipid peroxidation during preincubation. It is most
likely that vitamin E scavenged ROS generated by TNF stimulation and
consequently reduced TNF-induced apoptosis solely or
synergistically with DHA.
At the present time, it is unclear whether apoptosis induced by various
stimuli is harmful or beneficial in various physiological and
pathological circumstances. Induction of apoptosis and subsequent
ingestion of apoptotic cells by macrophages may prevent dangerous
immune responses or inflammation (Fadok et al. 1998
,
Gao et al. 1998
, Orteu et al. 1998
). On
the contrary, it has been reported that caspase inhibitors can protect
against ischemia of the liver (Cursio et al. 1999
) and
brain (Cheng et al. 1998
). TNF-induced apoptosis may
participate in rejection of organ transplants (Morel et al. 1993
), chronic hepatitis (Bradham et al. 1998
)
and acute pancreatitis (Norman 1998
). Our observations
indicate that nutrients such as DHA and vitamin E can attenuate
TNF-induced apoptosis of cultured cells. Taken together, it is
conceivable that ingestion of nutrients such as DHA and vitamin E can
reduce TNF-induced apoptosis and subsequently exert a beneficial
effect on organ dysfunction associated with various diseases.
| FOOTNOTES |
|---|
Manuscript received September 9, 1999. Initial review completed October 13, 1999. Revision accepted December 15, 1999.
| REFERENCES |
|---|
|
|
|---|
1.
Barroso M. P., Diaz C. G., Lluch G. L., Malagon M. M., Crane F. L., Navas P. Ascorbate and
-tocopherol prevent apoptosis induced by serum removal independent of Bcl-2. Arch. Biochem.Biophys. 1997;343:243-248[Medline]
2.
Beg A. A., Baltimore D. An essential role for NF-
B in preventing TNF-
-induced cell death. Science 1996;274:782-784
3. Beyaert R., Fiers W. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. FEBS Lett 1994;340:9-16[Medline]
4. Bligh E. G., Dyer W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959;37:911-917
5. Bradham C. A., Plumpe J., Manns M. P., Brenner D. A., Trautwein C. Mechanisms of hepatic toxicity?. TNF-induced liver injury. Am. J. Physiol. 1998;275:387-392
6. Brekke O. L., Shalaby M. R., Sundan A., Espevik T., Bjerve K. S. Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement. Cytokine 1992;4:269-280[Medline]
7. Calder P. C. n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann. Nutr. Metab. 1997;41:203-234[Medline]
8. Cheng Y., Deshmukh M., Costa A. D, Demaro J. A., Gidday J. M., Shah A., Sun Y., Jacquin M. F., Johnson E. M., Holtzman D. M. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 1998;101:1992-1999[Medline]
9.
Cursio R., Gugenheim J., Ricci J. E., Crenesse D., Rostagno P., Maulon L., Saint-Paul M. C., Ferrua B., Auberger A. P. A caspase inhibitor fully protects rats against lethal mormothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999;13:253-261
10. Enari M., Hug H., Hayakawa M., Ito F., Nishimura Y., Nagata S. Different apoptotic pathways mediated by FAS and the tumor-necrosis-factor receptor. Cytosolic phospholipase A2 is not involved in FAS-mediated apoptosis. Eur. J. Biochem. 1996;236:533-538[Medline]
11. Fadok V. A., bratton D. L., Konowal A., Freed P. W., Westcott J. Y., Henson P. M. Macrophoges that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-ß, PGE2 and PAF. J. Clin. Invest. 1998;101:890-898[Medline]
12. Fady C., Gardner A., Jacoby F., Briskin K., Tu Y., Schmid I., Lichtenstein A. Atypical apoptotic cell death induced in L929 targets by exposure to tumor necrosis factor. J. Interferon Cytokine Res. 1995;15:71-80[Medline]
13.
Gao B. Y., Herndon J. M., Zhang H., Griffith T. S., Ferguson T. A. Antiinflammatory effects of CD95 ligand (FASL)-induced apoptosis. J. Exp. Med. 1998;188:887-896
14.
Goossens V., Grooten J. K., Vos D., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1995;92:8115-8119
15. Green D. R. Apoptotic pathways: The roads to ruin. Cell 1998;94:695-698[Medline]
16. Haendeler J., Zeiher A. M., Dimmeler S. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur. J. Pharmacol. 1996;317:407-411[Medline]
17.
Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F., Tsujimoto M. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 1993;268:11290-11295
18. Hsu H., Shu H. B., Pan M. G., Goeddel D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84:299-308[Medline]
19. Ikeda K., Kajiwara K., Tanabe E., Tokumaru S., Kisida E., Masuzawa Y., Kojo S. Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells. Biochem. Pharmacol. 1999;57:1361-1365[Medline]
20.
Jayadev S., Linardic C. M., Hannun Y. A. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor
. J. Biol. Chem. 1994;269:5757-5763
21. Kishida E., Kasahara M., Takagi Y., Matsumura M., Hayashi T., Kobayashi S., Masuzawa Y. Evaluation of a trans configuration for the apoptosis-inducing activity of ceramide. J. Lipid Mediat. Cell Signal. 1997;16:127-137[Medline]
22. Kishida E., Yano M., Kasahara M., Masuzawa Y. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. Biochim. Biophys. Acta 1998;1391:401-408[Medline]
23.
Koseki T., Inohara N., Chen S., Nunez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc. Natl. Acad. Sci. U.S.A. 1998;95:5156-5160
24. Lai P.B. S., Ross J. A., Fearon K. C. H., Anderson J. D., Carter D. C. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br. J. Cancer 1996;74:1375-1383[Medline]
25.
Liu Z. G., Hsu H., Goeddel D. V., Karin M. Dissection of TNF recepter 1 effect function: JNK activation is not linked to apoptosis while NF-
B activation prevents cell death. Cell 1996;87:565-576[Medline]
26.
Manna S. K., Zhang H. J., Yan T., Oberley L. W., Aggarwal B. B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-
B and activated protein-1. J. Biol. Chem. 1998;273:13245-13254
27.
Mayer M., Noble M. N-Acetyl-L-cysteine is a pluripotent
protector against cell death and enhancer of trophic
factor-mediated cell survival in vitro. Proc. Natl. Acad. Sci.
U.S.A. 1994;91:7496-7500
28. Morel D., Normand E., Lemoine C., Merlio J. P., Velours J., Astier T., Bonnet F., Aparicio M., Potaux L., Bloch B. Tumor necrosis factor alpha in human kidney transplant rejection-analysis by in situ hybridization. Transplantation 1993;55:773-777[Medline]
29.
Munoz E., Blazquez M. V., Ortiz C., Gomez-Diaz C., Navas P. Role of ascorbate in the activation of NF-
B by tumour necrosis factor-
in T-cells. Biochem. J. 1997;325:23-28
30. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am. J. Surg. 1998;175:76-83[Medline]
31.
Orteu C. H., Poulter L. W., Rustin M. H. A., Sabin C. A., Salmon M., Akbar A. N. The role apoptosis in the resolution of T cell-mediated cutaneous inflammation. J. Immunol. 1998;161:1619-1629
32. Palombella V. J., Vilcek J. Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation. J. Biol. Chem. 1989;264:18128-18136
33.
Perry D. K., Smyth M. J., Stennicke H. R., Salvesen G. S., Duriez P., Poirier G. G., Hannun Y. A. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. J. Biol. Chem. 1997;272:18530-18533
34.
Seegers J. C., Kock M. D., Lottering M. L., Grobler C. J. S., Van Papendorp D. H., Shou Y., Habbersett R., Lehnert B. E. Effects of
-linolenic acid and arachidonoic acid on cell cycle progression and apoptosis induction in normal and transformed cells. Prostaglandins Leukot. Essent. Fatty Acids. 1997;56:271-280[Medline]
35.
Seol D. W., Nunez T. R. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J. Biol. Chem. 1999;274:2072-2076
36. Shikano M., Masuzawa Y., Yazawa K. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1. J. Immunol. 1993;150:3525-3533[Abstract]
37. Shikano M., Masuzawa Y., Yazawa K., Takayama K., Kudo I., Inoue K. Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine. Biochim. Biophys. Acta 1994;1212:211-216[Medline]
38.
Simopoulos A. P. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 1991;54:438-463
39. Straface E., Santini M. T., Donelli G., Giacomoni P. U., Malorni W. Vitamin E prevents UVB-induced cell blebbing and cell death in A431 epidermoid cells. Int. J. Radiat. Biol. 1995;68:579-587[Medline]
40. Suffys P., Beyaert R., Roy F. V., Fiers W. Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochem. Biophys. Res. Commun. 1987;149:735-743[Medline]
41. Tracey K. J., Cerami A. C. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 1993;9:317-343
42.
Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M. Suppression of TNF-
-induced apoptosis by NF-
B. Science 1996;274:787-789
43.
Van Antwerp D. J., Martin S. J., Verma I. M., Green D. R. Inhibition of TNF-induced apoptosis by NF-
B. Trends Cell Biol 1998;8:107-111[Medline]
44. Voelkel-Johnson C., Thorne T. E., Laster S. M. Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells. J. Immunol. 1996;156:201-207[Abstract]
45.
Wang C. Y., Mayo M. W., Baldwin A. S. Jr TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-
B. Science 1996;274:784-787
46.
Wissing D., Mouritzen H., Egeblad M., Poirier G. G., Jaattela M. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 1997;94:5073-5077
47. Wong G. H. W., Elwell J. H., Oberley L. W., Goeddel D. V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989;58:923-931[Medline]
48.
Wu Y. L., Jiang X. R., Newland A. C., Kelsey S. M. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J. Immunol. 1998;160:5929-5935
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||